Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
HCC1500 | AZD7762 | CHK1/2 | Cell cycle | 0.035943 | -0.2559 | 0.6218 | 0.1217 | 1.0434 | 0.037616 | 0.91391 |
HCC1395 | Luminespib | HSP90 | Misc | 0.0049953 | -0.1520 | 0.6195 | 0.0752 | 3.9193 | 0.0052747 | 0.99634 |
HCC1954 | Luminespib | HSP90 | Misc | 0.010331 | -0.3745 | 0.6188 | 0.2958 | 2.6936 | 0.012628 | 0.99618 |
HCC1500 | Taxol | Chemo | Chemotherapy | 0.0038131 | -0.0589 | 0.6182 | 0.1433 | 1.8138 | 0.0038924 | 0.96247 |
HCC1954 | Bleomycin | Radiation | Misc | 0.043847 | -0.0884 | 0.6166 | 0.2476 | 0.7506 | 0.05535 | 0.98102 |
Hs 578T | Dinaciclib | pan CDK | Cell cycle | 0.0089363 | -0.2388 | 0.6160 | 0.2121 | 4.9934 | 0.0096082 | 0.99916 |
T47D | Everolimus | mTOR1 | PI3K/mTOR | -Inf | 0.2975 | 0.6157 | 0.0150 | 0.1000 | 5.9599e-07 | 0.77906 |
MDA-MB-157 | Luminespib | HSP90 | Misc | 0.0041789 | -0.0490 | 0.6146 | 0.0676 | 4.3520 | 0.004258 | 0.99849 |
HCC1954 | Volasertib | PLK | Cell cycle | 0.0065835 | -0.1540 | 0.6139 | 0.2792 | 3.4968 | 0.0071308 | 0.99812 |
MCF 10A | Luminespib | HSP90 | Misc | 0.0076226 | -0.1717 | 0.6131 | 0.2622 | 3.1403 | 0.0083878 | 0.9999 |
CAMA-1 | Abemaciclib | CDK4/6 | Cell cycle | 0.007859 | 0.2222 | 0.6130 | -0.0040 | 1.3608 | 0.0046978 | 0.97968 |
BT-549 | Luminespib | HSP90 | Misc | 0.0053858 | -0.1064 | 0.6123 | 0.1201 | 5.0000 | 0.0055748 | 0.99911 |
MDA-MB-361 | Buparlisib | pan PI3K | PI3K/mTOR | 0.21797 | -0.9584 | 0.6114 | 0.1763 | 0.9709 | 0.67584 | 0.99384 |
SUM1315MO2 | Luminespib | HSP90 | Misc | 0.0048627 | -0.0810 | 0.6112 | 0.1374 | 5.0000 | 0.0050309 | 0.99738 |
PDX1258 | Luminespib | HSP90 | Misc | 0.01007 | -0.2899 | 0.6101 | 0.1943 | 5.0000 | 0.011049 | 0.99799 |
MDA-MB-157 | Etoposide | Topo II | Chemotherapy | 0.11187 | -0.4340 | 0.6092 | 0.0639 | 1.5161 | 0.15792 | 0.98866 |
MCF7 | Volasertib | PLK | Cell cycle | 0.0028671 | -0.0338 | 0.6070 | 0.1245 | 4.2176 | 0.002824 | 0.99423 |
HCC1395 | Bleomycin | Radiation | Misc | 0.10419 | -0.4023 | 0.6070 | 0.1775 | 0.6889 | 0.30452 | 0.9971 |
SUM159PT | Doxorubicin | Chemo | Chemotherapy | 0.019121 | -0.2740 | 0.6068 | 0.2965 | 1.5857 | 0.022541 | 0.98806 |
CAMA-1 | Dinaciclib | pan CDK | Cell cycle | 0.014558 | -0.4849 | 0.6062 | 0.1927 | 2.0283 | 0.019954 | 0.99839 |
PDXHCI002 | Dinaciclib | pan CDK | Cell cycle | 0.012194 | -0.3607 | 0.6030 | 0.2029 | 4.6252 | 0.01372 | 0.99728 |
MCF7 | Torin2 | mTOR/ATM/ATR | PI3K/mTOR | 0.0045641 | -0.1330 | 0.6027 | 0.1279 | 0.9398 | 0.0052657 | 0.98973 |
CAL-120 | INK-128 | mTORC1/2 | PI3K/mTOR | 0.011487 | -0.0097 | 0.6018 | 0.0545 | 1.3448 | 0.011154 | 0.99759 |
HCC1395 | Dasatinib | BCR/ABL | MAPK/nRTK | 0.074545 | -0.3369 | 0.6018 | 0.0918 | 1.9595 | 0.089698 | 0.98974 |
MDA-MB-361 | Dinaciclib | pan CDK | Cell cycle | 0.011817 | -0.2748 | 0.6004 | 0.0836 | 5.0000 | 0.013067 | 0.99187 |